These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12662122)

  • 21. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
    McGeer PL
    Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drug (NSAID) use and Alzheimer disease in community-dwelling elderly patients.
    Landi F; Cesari M; Onder G; Russo A; Torre S; Bernabei R
    Am J Geriatr Psychiatry; 2003; 11(2):179-85. PubMed ID: 12611747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of Alzheimer's disease.
    Gauthier S
    Ann Med Interne (Paris); 1998 Jun; 149(4):228-30. PubMed ID: 11490550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.
    Szekely CA; Thorne JE; Zandi PP; Ek M; Messias E; Breitner JC; Goodman SN
    Neuroepidemiology; 2004; 23(4):159-69. PubMed ID: 15279021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Alzheimer's Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs?
    Lehrer S; Rheinstein PH
    Am J Alzheimers Dis Other Demen; 2015 May; 30(3):225-7. PubMed ID: 25100747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
    Rich JB; Rasmusson DX; Folstein MF; Carson KA; Kawas C; Brandt J
    Neurology; 1995 Jan; 45(1):51-5. PubMed ID: 7824134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NSAIDs and incident Alzheimer's disease. The Rotterdam Study.
    in 't Veld BA; Launer LJ; Hoes AW; Ott A; Hofman A; Breteler MM; Stricker BH
    Neurobiol Aging; 1998; 19(6):607-11. PubMed ID: 10192221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?
    Ho L; Qin W; Stetka BS; Pasinetti GM
    CNS Drugs; 2006; 20(2):85-98. PubMed ID: 16478285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?
    Karplus TM; Saag KG
    Drug Saf; 1998 Dec; 19(6):427-33. PubMed ID: 9880087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of dementia and Alzheimer's disease.
    Hendrie HC
    Am J Geriatr Psychiatry; 1998; 6(2 Suppl 1):S3-18. PubMed ID: 9581216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study.
    Zandi PP; Anthony JC; Hayden KM; Mehta K; Mayer L; Breitner JC;
    Neurology; 2002 Sep; 59(6):880-6. PubMed ID: 12297571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.
    Szekely CA; Zandi PP
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):132-9. PubMed ID: 20205647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Trends in nonsteroidal anti-inflammatory drug development and application].
    Miedzybrodzki R
    Postepy Hig Med Dosw (Online); 2004; 58():438-48. PubMed ID: 15577751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study.
    Yip AG; Green RC; Huyck M; Cupples LA; Farrer LA;
    BMC Geriatr; 2005 Jan; 5():2. PubMed ID: 15647106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    McGeer PL; Rogers J; McGeer EG
    J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal.
    Breitner JC
    Neurobiol Aging; 1996; 17(5):789-94. PubMed ID: 8892353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.